SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-069785
Filing Date
2024-06-07
Accepted
2024-06-07 19:25:09
Documents
1
Period of Report
2024-06-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2416741-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2416741-3_4seq1.xml 4 3813
  Complete submission text file 0001104659-24-069785.txt   5424
Mailing Address C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address
Glickman Mark A (Reporting) CIK: 0001441461 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37809 | Film No.: 241031166

Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Issuer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)